As schools of all levels struggle to find a new way to educate students, universities, in particular, have had a difficult time navigating classes and campus life. On this week's show, we talk to a student navigating quarantined dorm life at the University of Wisconsin-Madison and a scientist who helped design a different approach to testing for the University of Illinois at Urbana-Champaign.

On this week’s episode of PODCAST-19, we discuss whether the FDA vaccine approval process can withstand political interference and how the agency can reassure the public that everything is working as it should.

We discuss the news that AstraZeneca's COVID-19 vaccine trial has been paused because of a severe side effect for one participant, and how temporarily halting a trial can sometimes mean the process is working as intended.

The U.S. doesn't want to participate in a global effort to find and distribute a vaccine for COVID-19. Anna talks with FiveThirtyEight senior science writer Maggie Koerth about what that decision might mean for the country and the world.

On this week's episode, we explore what it means that people can get reinfected with COVID-19, and how we can still develop immunity to the disease. We also explore why the approach to masks in the Netherlands is so much more lax than in parts of the U.S., even though Holland has done a better job of suppressing COVID-19.

Russia is the first country in the world to approve a vaccine for COVID-19. To do so, they’ve reportedly sped through multiple steps in the testing process. Judy Twigg, a political scientist from Virginia Commonwealth University, talks about the state of medical research in Russia, and the political implications of this move. Also, we hear about the people who want to get COVID, for science! And we explore a new vaccine with promising early results.

We were no match for extreme weather this week, but we'll be back next week!

This week on Podcast-19, we talk about lab-grown antibodies, called monoclonal antibodies, that could temporarily protect people from COVID-19. How soon might they be available for the public? We also explore the long history of a COVID drug touted as a lifesaver, and learn about an inhalable treatment that might keep coronavirus patients off ventilators.

Who has access to COVID-19 testing in America? FiveThirtyEight and ABC News uncover some staggering disparities along racial lines. Also on today’s show, what are safe activities these days? Can you take a taxi? Eat outside at a restaurant? Senior Science Writer Maggie Koerth explores COVID’s murky middle. And finally, we check in on our oceans’ humpback whales. Yes, whales. On a coronavirus podcast.

Mask mandates have become a polarizing issue across the country, from Arizona to Georgia. So, where do we draw the line between public health and civil liberties? Also, we talk about air -- how can buildings ensure it's safe to breathe during the pandemic? And finally, some good vaccine news.

Anna Rothschild interviewed Dr. Anthony Fauci about how the U.S. is doing compared to other countries, how American partisanship has influenced our recovery efforts, and how a COVID-19 vaccine might influence the future of vaccine acceptance in our country.

How do you convey information about the coronavirus in a way that will compel people to change their behavior? As COVID cases rise in Florida, Texas, and Arizona, we look at how psychologists recommend we talk about public health.

Maggie Koerth and Kaleigh Rogers join the show to discuss the science of face masks, and whether we actually know anything now that we didn't when the pandemic started.

Creating a vaccine for COVID-19 is just the first step. Policy makers and manufacturers then need to make a lot of it. So, who will be first in line for the immunization?

A major medical journal reported that hydroxychloroquine harmed COVID patients, but a group of Twitter sleuths uncovered evidence that the paper wasn't what it seemed.

Black Americans are facing two crises: a pandemic that has an outsize impact on their community, and decades of police brutality that have sparked protests nationwide.

Plus, why have Americans retained their trust in science despite protests against its findings? And finally, the good news is poopy news this week.

One man's story helps show who is going uncounted in the COVID-19 death count. Elsewhere, there's some promising immunity news to share.

Without a vaccine, just how likely are we to reach herd immunity? Also, we hear some good news about COVID-19 antibodies -both in humans and...llamas?!

Experts say that to fight COVID-19 we need to track every infection. But is it too late? Also, we investigate why the disease is killing more men than women.

And why are some young people getting so sick? Find out on FiveThirtyEight's new COVID-19 podcast.

FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We...